Physician profile
Mitchell Vogel
NPI 1891799771
$4,191.60
in general payments reported to CMS, 2019-2025
22 companies · $411 in 2025
The $411 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $38.80 · 2021: $73.99 · 2022: $196 · 2023: $2,125 · 2024: $1,045 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $1,799 · Food and Beverage: $1,684 · Education: $97.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $1,799.23 |
| Food and Beverage | $1,683.90 |
| Education | $97.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tearlab Corp | $1,799.23 | 2023 | Tearlab Osmolarity System |
| Bausch & Lomb Americas INC. | $627.48 | 2024-2025 | Xiidra, Miebo, Xipere |
| Tarsus Pharmaceuticals, INC. | $470.03 | 2024-2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $279.07 | 2023-2024 | Acthar |
| Dompe US, INC. | $153.51 | 2019-2025 | Oxervate |
| Biotissue Holdings INC. | $148.88 | 2022-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $141.04 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $120.11 | 2019 | |
| Oyster Point Pharma, INC. | $110.80 | 2022-2023 | Tyrvaya |
| Kala Pharmaceuticals, INC. | $55.55 | 2021-2022 | |
| Insulet Corporation | $50.21 | 2025 | Omnipod |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Harrow Eye, LLC | $34.12 | 2024-2025 | Vevye |
| Abbvie INC. | $26.45 | 2022 | |
| Sun Pharmaceutical Industries INC. | $22.79 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $20.33 | 2024 | Misight Contact Lens |
| Sight Sciences, INC. | $20.21 | 2024 | Tearcare System |
| Alimera Sciences, INC. | $16.66 | 2024 | Iluvien, Yutiq |
| Tolmar, INC. | $16.64 | 2024 | |
| Novo Nordisk INC | $13.89 | 2019 | |
| Aerie Pharmaceuticals, INC. | $13.26 | 2021 | |
| Alcon Vision LLC | $12.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Vogel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.